Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-032851
Filing Date
2014-09-30
Accepted
2014-09-30 20:03:05
Documents
1
Period of Report
2014-09-29

Document Format Files

Seq Description Document Type Size
1 rrd416842.html 4  
1 rrd416842.xml 4 6843
  Complete submission text file 0001181431-14-032851.txt   8325
Mailing Address 10445 PACIFIC CENTER CT SAN DIEGO CA 92121
Business Address
LONGENECKER JOHN P PHD (Reporting) CIK: 0001288231 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35060 | Film No.: 141130925

Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Issuer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations